Guavita-Navarro Diana, Gallego-Cardona Laura, Arredondo Ana María, Cubides Hector, Cajamarca-Barón Jairo, Ibáñez Claudia, Escobar Alejandro, Rojas-Villarraga Adriana
Department of Rheumatology, Hospital de San José, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, 111221, Colombia.
Research Division, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, 111221, Colombia.
J Transl Autoimmun. 2021 Nov 10;4:100133. doi: 10.1016/j.jtauto.2021.100133. eCollection 2021.
: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a wide range of clinical manifestations. The latest classification criteria, EULAR/ACR 2019, have not been validated in a Latin American population of Amerindian ancestry. The objective of this study is to compare the sensitivity of the EULAR/ACR 2019 and SLICC 2012 classification criteria in a group of SLE patients with the above ancestry.
A cross-sectional study was done. Data were obtained from the review of medical records of patients who met the inclusion criteria. The overall sensitivity of the criteria was calculated and compared to each other using the McNemar test.
146 medical records of patients from two referral centers were included. There were no differences in the sensitivity of the EULAR/ACR and SLICC 2012 criteria (84.9% versus 85.6% p = 0.79) nor were differences found when the groups based on disease duration were compared: less than 5 years (91.0% versus 92.5% p = 0.70), between 5 and 10 years (82.8% versus 82.8% p = 1), and 10 years or more (76.7% versus 76.7% p = 1). However, SLICC 2012 criteria was found to better classify patients with a less than 5-year disease duration compared to those with 10-year duration or more (92.5% versus 76.4% p = 0.024).
There are no statistically significant differences between the EULAR/ACR and SLICC 2012 criteria in the population studied. Nor were differences found when evaluating them by age at diagnosis and duration of the disease except when the group with less than 5 years of duration was compared to those with 10 years or more using the SLICC 2012 criteria.
系统性红斑狼疮(SLE)是一种多系统自身免疫性疾病,临床表现广泛。最新的分类标准,即欧洲抗风湿病联盟/美国风湿病学会(EULAR/ACR)2019标准,尚未在拉丁美洲有美洲印第安人血统的人群中得到验证。本研究的目的是比较EULAR/ACR 2019标准和2012年系统性红斑狼疮国际协作临床(SLICC)分类标准在一组具有上述血统的SLE患者中的敏感性。
进行了一项横断面研究。数据来自对符合纳入标准患者的病历回顾。计算标准的总体敏感性,并使用McNemar检验进行相互比较。
纳入了来自两个转诊中心的146例患者的病历。EULAR/ACR标准和2012年SLICC标准的敏感性没有差异(分别为84.9%和85.6%,p = 0.79),按疾病病程分组比较时也未发现差异:病程小于5年(分别为91.0%和92.5%,p = 0.70)、病程5至10年(分别为82.8%和82.8%,p = 1)、病程10年或更长(分别为76.7%和76.7%,p = 1)。然而,发现2012年SLICC标准在对病程小于5年的患者进行分类时比病程10年或更长的患者更好(分别为92.5%和76.4%,p = 0.024)。
在研究人群中,EULAR/ACR标准和2012年SLICC标准之间没有统计学上的显著差异。在按诊断年龄和疾病病程评估时也未发现差异,但使用2012年SLICC标准比较病程小于5年的组与病程10年或更长的组时除外。